Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118515585A reveals metal-free alkenyl cyanide synthesis. High yield, trans-selective. Reliable supplier for pharma intermediates.
Patent CN101045936B details a novel enzymatic resolution process using succinic anhydride, offering significant cost reduction and simplified purification for pharmaceutical intermediates.
Patent CN111592487B reveals potent dual-target anticancer agents. Efficient synthesis offers cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113773214A reveals a scalable four-step route for N-methyl-D-threonine, eliminating chromatography for significant cost reduction in pharmaceutical manufacturing.
Patent CN101955415B details a high-yield route for 2-hydroxyl biphenyl using 9-fluorenone. Discover cost-effective manufacturing and supply chain advantages.
Patent CN102190613B reveals a high-yield carvedilol synthesis avoiding hydrogenation. Ideal for reliable carvedilol intermediate suppliers seeking cost reduction.
Advanced two-step crystallization technology for Azilsartan refining. Achieves >99.85% purity and eliminates critical impurities. Cost-effective API manufacturing solution.
Novel urea-based route for 1 3-adamantanediamine offers high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable supply chain reliability.
Patent CN104830704A details a recombinant Candida parapsilosis strain producing (R)-phenylethylene glycol with 99.9% ee. Offers cost reduction and supply reliability for pharma intermediates.
Patent CN113387877B details a novel synthesis for Sodium Picosulfate using sulfamic acid, offering superior purity and reduced inorganic residues for pharmaceutical manufacturing.
Novel MnO2/m-CPBA method for phenanthrene and biphenyl derivatives. Reduces toxicity, improves yield for pharmaceutical intermediate manufacturing.
Patent CN114507230A reveals a green synthesis route for bicyclic pyridone intermediates using citric acid, offering cost reduction and supply chain reliability for API manufacturing.
Patent CN105503822B offers low-cost iron-catalyzed route for high-purity intermediates. Enhance supply chain reliability with scalable manufacturing.
Patent CN113683496A details a novel synthetic route for Agrimonol B and Pseudoaspidinol, offering cost reduction in API manufacturing through safer reagents and higher yields.
Patent CN105503822B reveals a novel FeCl3-catalyzed synthesis for trifluoromethyl benzothiophenes, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel metal-free synthesis of ortho-haloarylamines using dihalo sulfoxide. High regioselectivity, mild conditions, ideal for reliable pharmaceutical intermediate supply chains.
Novel patent CN109836408A enables high-yield binaphthyl crown ether production. Offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Advanced KI-catalyzed synthesis improves yield and safety for herbicide intermediates. Cost-effective scaling and high purity ensure reliable agrochemical supply chains.
Patent CN101880241A reveals a safer one-pot Curtius rearrangement for Candesartan intermediates, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN105175400A details zinc-based reduction for Afatinib intermediates offering high purity and reduced pollution for pharmaceutical manufacturing supply chains.